HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Leslie Popplewell Selected Research
Leslie Popplewell Research Topics
Disease
12
Neoplasms (Cancer)
01/2022 - 04/2002
10
Hodgkin Disease (Hodgkin's Disease)
01/2022 - 09/2005
10
Lymphoma (Lymphomas)
01/2021 - 09/2005
7
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 06/2006
7
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 09/2005
7
Leukemia
10/2016 - 02/2002
6
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2022 - 06/2006
5
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2017 - 03/2011
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2014 - 02/2002
3
Multiple Myeloma
01/2022 - 06/2010
3
Fatigue
01/2020 - 03/2011
3
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 04/2005
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 03/2011
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2019
2
Anemia
01/2021 - 03/2011
2
Hematologic Neoplasms (Hematological Malignancy)
02/2016 - 04/2002
2
Exanthema (Rash)
01/2016 - 01/2014
2
Diarrhea
01/2016 - 01/2014
2
Nausea
01/2016 - 01/2014
2
T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 10/2011
2
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2011 - 08/2011
1
Bacteremia
12/2021
1
Central Nervous System Diseases (CNS Diseases)
01/2021
1
Febrile Neutropenia
01/2021
1
Body Weight (Weight, Body)
11/2018
1
Rheumatoid Arthritis
11/2018
1
Pathologic Complete Response
12/2015
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2015
1
Disease Progression
03/2015
1
Vomiting
01/2014
1
Mycosis Fungoides
08/2012
Drug/Important Bio-Agent (IBA)
7
Rituximab (Mabthera)
FDA Link
01/2022 - 03/2015
3
Chimeric Antigen Receptors
IBA
01/2022 - 09/2010
3
Prednisone (Sone)
FDA Link
Generic
01/2021 - 04/2005
3
Brentuximab Vedotin
IBA
01/2020 - 11/2014
3
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2020 - 04/2005
3
Vorinostat
FDA Link
01/2020 - 03/2011
2
Melphalan (Alkeran)
FDA Link
Generic
01/2022 - 03/2012
2
Etoposide (VP 16)
FDA Link
Generic
01/2022 - 10/2005
2
CT-P10
IBA
01/2022 - 11/2018
2
Antigens
IBA
01/2021 - 09/2010
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021 - 10/2005
2
Tacrolimus (Prograf)
FDA Link
Generic
01/2019 - 04/2005
2
romidepsin (FK228)
FDA Link
10/2017 - 07/2015
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2016 - 01/2014
2
Pharmaceutical Preparations
IBA
01/2014 - 03/2011
2
10-propargyl-10-deazaaminopterin
FDA Link
08/2012 - 03/2011
1
polatuzumab vedotin
IBA
06/2022
1
atezolizumab
IBA
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Carboplatin (JM8)
FDA Link
Generic
01/2022
1
tisagenlecleucel
IBA
01/2022
1
B7-H1 Antigen
IBA
01/2022
1
tazemetostat
IBA
01/2022
1
Ice
IBA
01/2022
1
Ifosfamide
FDA Link
Generic
01/2022
1
Nivolumab
IBA
01/2022
1
ibrutinib
IBA
01/2021
1
Lenalidomide (CC 5013)
FDA Link
01/2021
1
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2021
1
Vincristine (Oncovin)
FDA Link
Generic
01/2021
1
Aurora Kinase A
IBA
01/2020
1
MLN 8237
IBA
01/2020
1
utomilumab
IBA
01/2020
1
Histone Deacetylase Inhibitors
IBA
01/2020
1
Ipilimumab
IBA
12/2019
1
Sirolimus (Rapamycin)
FDA Link
01/2019
1
SOXC Transcription Factors
IBA
01/2019
1
Biosimilar Pharmaceuticals
IBA
11/2018
1
Immune Checkpoint Inhibitors
IBA
11/2018
1
magrolimab
IBA
11/2018
1
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
10/2016
1
Antisense Oligonucleotides
IBA
10/2016
1
GTI2040
IBA
10/2016
1
Oxidoreductases (Dehydrogenase)
IBA
10/2016
1
Messenger RNA (mRNA)
IBA
10/2016
1
RG7112
IBA
02/2016
1
trametinib
IBA
01/2016
1
MAP Kinase Kinase 1
IBA
01/2016
1
Mitogen-Activated Protein Kinases
IBA
01/2016
1
Alanine Transaminase (SGPT)
IBA
01/2016
1
AZD 6244
IBA
01/2014
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2014
1
Clofarabine (Clolar)
FDA Link
03/2012
1
N 30
IBA
10/2011
1
Proteins (Proteins, Gene)
FDA Link
03/2011
Therapy/Procedure
14
Therapeutics
01/2022 - 02/2002
8
Cell Transplantation
01/2022 - 09/2005
8
Stem Cell Transplantation
01/2019 - 10/2005
3
Salvage Therapy
01/2022 - 04/2005
3
Drug Therapy (Chemotherapy)
01/2017 - 04/2002
2
Autologous Transplantation
01/2022 - 12/2015
2
Homologous Transplantation
11/2014 - 12/2006
2
Radiotherapy
11/2012 - 04/2002
2
Hematopoietic Stem Cell Transplantation
09/2010 - 02/2003
1
Catheters
12/2021
1
Radioimmunotherapy
12/2021
1
Combination Drug Therapy (Combination Chemotherapy)
12/2015
1
Oral Surgery (Maxillofacial Surgery)
11/2012
1
Breast Implants (Breast Implant)
08/2011